U.S. Retail Distributors Stock News

Ever wondered if Jacobs Solutions is truly trading at a bargain or if the market has it priced just right? Let’s take a closer, no-nonsense look at where it might stand today. The stock is up an impressive 93.5% over the past five years and still holds a 16.0% gain year-to-date, despite a slight dip of 4.2% in the past week. Markets have taken notice of Jacobs Solutions as headlines cite its expansion into infrastructure modernization projects and recent high-profile contract wins. This has...

Regencell Bioscience Holdings (RGC) just released its latest earnings report, showing its annual net loss narrowed from the previous year. Despite slight improvement, the stock remains volatile with ongoing negative financial fundamentals. See our latest analysis for Regencell Bioscience Holdings. Regencell Bioscience Holdings has seen wild swings lately, especially after narrowing its annual net loss. While the latest 1-day and 7-day share price returns dropped sharply, the stock's...

Curious if Hertz Global Holdings is a bargain or a bounce trap? You're not alone, and we're diving deep to see just how much value might be hiding in the numbers. The stock has rocketed up 32.4% year to date and gained an impressive 69.8% over the past year, even though it has dipped 4.4% in the last week and 21.0% over the past month. Momentum has largely been sparked by renewed attention on the used car market and shifting consumer travel habits, both of which put Hertz in the spotlight...

Primoris Services (PRIM) just delivered stronger-than-expected third quarter results, with both sales and net income rising considerably from a year earlier. The company also raised its full-year earnings guidance, which signals ongoing momentum. See our latest analysis for Primoris Services. Alongside its upbeat earnings release and a fresh dividend declaration, Primoris Services has enjoyed a remarkable run. Its share price is up 86% year-to-date, while total shareholder return over the...

Prudential Financial recently announced third quarter 2025 results, reporting net income of US$1.43 billion, up from US$448 million a year earlier, with diluted earnings per share from continuing operations rising to US$4.01 from US$1.24. This earnings release also highlighted the completion of a major share buyback tranche, totaling nearly US$751 million since December 2024 and reflecting management's confidence in the company's trajectory. We'll explore how Prudential's strong quarterly...

Netflix (NFLX) made headlines this week as the company revealed a 10-for-1 stock split, set to take effect after the closing bell on November 14. Beginning November 17, shares will start trading at the new split-adjusted price. See our latest analysis for Netflix. Netflix’s announcement of a stock split comes after an eventful period that has kept the spotlight firmly on the company. Not only has it made headlines with a 3.7% post-announcement rally, but it has also been actively exploring...

Natural Resource Partners L.P. reported its third quarter 2025 financial results, revealing lower revenue and net income year-over-year due to ongoing weak coal and soda ash pricing, and announced a US$0.75 per unit cash distribution payable on November 25, 2025. Despite challenging market conditions and a dropped carbon sequestration lease, the company emphasized continued free cash flow generation and its focus on deleveraging while maintaining regular distributions. We'll explore how...

Wondering if Meta Platforms is truly worth its current price? You are not alone, as plenty of investors are keen to know whether there's real value or just hype behind the stock. The stock has taken a breather lately, sliding 15.1% in the past week and down 10.3% over the last month. However, it is still up an impressive 6.4% year-to-date and 14.1% over the past year. Recent headlines have revolved around Meta’s latest advancements in artificial intelligence and its push into new hardware...

PennyMac Mortgage Investment Trust (PMT) has drawn renewed attention as investors look for direction after recent price moves. With the stock’s performance showing little change over the past week, many are examining the underlying numbers for clues on future trends. See our latest analysis for PennyMac Mortgage Investment Trust. Looking at the bigger picture, PennyMac Mortgage Investment Trust’s recent share price softness follows a period of steady progress, with total shareholder returns...

Under Armour (UAA) stock has underperformed, down 32% over the past 3 months. Shares are currently trading around $4.57. This has prompted investors to reassess the company’s recent performance and outlook for value moving forward. See our latest analysis for Under Armour. After tumbling nearly 32% over the past quarter, Under Armour’s share price has lost momentum. The company capped off a year with a 47% total shareholder return decline. This ongoing weakness suggests investors are...

Wondering if Novavax is a bargain or a big risk right now? You are not alone; there is plenty of debate around whether the current price reflects the company's true value. The stock price has dropped 9.1% in the last week and 16.4% over the past month, fueling questions about both its future growth and potential risks. Recent headlines have focused on Novavax securing new funding initiatives and expanding vaccine partnerships, which has added fresh perspective (and volatility) to the share...

Curious if Ferrari’s high-octane brand translates into real stock market value? Let’s cut through the hype and answer the ultimate question: is Ferrari worth its share price right now? The last month has not been kind to Ferrari shareholders, with the stock dropping 21.8%. It is also down 17.0% over the past year, despite a doubling over three years. Recent headlines have centered on Ferrari’s moves into luxury lifestyle products and partnerships with high-profile brands. This has fueled...

Dover Corporation recently reported its third-quarter 2025 results, showing sales of US$2,077.84 million and net income of US$302 million, while also issuing full-year 2025 earnings guidance with GAAP EPS expected between US$8.06 and US$8.16 and revenue growth of 4% to 6%. Amid ongoing buyback activity earlier in the year, Dover reported higher sales but lower net income versus the previous year, offering investors fresh insight into both operational performance and forward...

NIO (NYSE:NIO) shares have seen a recent uptick, gaining 2% over the past day and 5% this week. Investors are weighing the company's steady revenue growth and sharp improvement in annual net income, while also considering lingering longer-term performance questions. See our latest analysis for NIO. After a stellar 64.9% share price return over the past 90 days, NIO’s recent gains suggest momentum is building once again, despite a setback earlier in the month. Still, with a five-year total...

Investors in Cytokinetics (CYTK) are reacting after news surfaced of a class action lawsuit claiming the company misrepresented key aspects of its aficamten drug approval timeline and related regulatory risks. See our latest analysis for Cytokinetics. Despite the recent legal headlines putting pressure on sentiment, Cytokinetics shares are still up 22.7% so far this year, supported by strong momentum from a remarkable 70.8% 90-day share price return and a five-year total shareholder return of...

Wondering if Guidewire Software might be undervalued or overheated? If you are on the hunt for value in software stocks, you probably have questions about whether Guidewire is worth a closer look right now. The stock has seen a bit of everything recently, climbing an impressive 34.5% year-to-date and 22.9% over the past year, but dropping 9.9% in the last week. That kind of movement often means investors are rethinking what Guidewire could be worth. One factor...

Fortune Brands Innovations (FBIN) shares have drifted lower lately, edging down about 4% over the past month and slipping nearly 11% over the past 3 months. Investors are watching closely as the company navigates shifting market dynamics. See our latest analysis for Fortune Brands Innovations. While Fortune Brands Innovations’ share price has slipped 25% year-to-date, recent moves reflect a gradual cooling of momentum that mirrors the company’s broader, longer-term picture. With a one-year...

On November 3, 2025, Realty Income Corporation reported third-quarter results with revenue of US$1.47 billion and net income of US$315.77 million, raising its 2025 investment volume guidance to approximately US$5.5 billion while maintaining strong rent recapture rates and updating its earnings outlook. An important insight is Realty Income's expanding investment in European markets, which now accounts for the majority of new investment volume and signals a focus on global portfolio growth...

Wondering if Chart Industries is a hidden gem or already fairly priced? You are not alone. There are plenty of signals worth digging into today. Despite a modest dip of 0.1% over the past week and 0.6% over the last month, Chart Industries has delivered an impressive 41.0% return for shareholders over the last year and a remarkable 119.1% return over five years, signaling strong long-term potential. Momentum around the stock has followed several notable deals in the industrial gas and energy...

Wondering if Fair Isaac is a hidden bargain or if its sky-high share price is actually justified? You are not alone, and today we are diving into what really drives its value. The stock has seen its ups and downs lately, sliding 2.1% over the last week and dropping 10.8% in the past month. This has contributed to a year-to-date decline of 17.3%. Despite the recent weakness, Fair Isaac has still delivered an impressive 277.8% return over three years. Market sentiment around Fair Isaac has...

Immunome (IMNM) presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, a venue where companies frequently discuss new developments in oncology research. These developments can shape investor expectations. See our latest analysis for Immunome. Immunome's momentum has noticeably picked up. Its share price jumped more than 37% over the past month and is now up over 61% for the year to date. Longer-term, its one-year total shareholder...

DoorDash (DASH) shares have drifted downward in recent weeks, slipping around 11% over the past month. Investors seem to be weighing valuation after a year of strong gains, even as the company reported double-digit annual revenue and net income growth. See our latest analysis for DoorDash. Despite some recent softness, DoorDash’s momentum this past year is hard to ignore. While the share price has pulled back roughly 11% over the past month, its year-to-date share price return remains...

Ever wondered if Ascendis Pharma is a hidden gem or if the recent buzz is justified? Let’s break down what might really be driving the current price. The stock has seen some ups and downs lately, dipping by 1.1% over the past week and 1.5% in the last month. It still boasts a strong 45.6% gain year-to-date and an impressive 59.8% return over the past year. Much of this momentum has been shaped by recent news highlighting pipeline updates and regulatory milestones, which have kept investors...

Cummins (CMI) has delivered a steady performance lately, catching the eye of investors looking for consistent industrial names. Shares have risen nearly 4% over the past week and 17% during the past 3 months. See our latest analysis for Cummins. Looking at the bigger picture, Cummins continues to build positive momentum, with a 1-year total shareholder return of 37.2% highlighting strong value creation for investors. After a solid year and with the latest share price at $437.71, the company’s...